Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Omission in Funding/Support

Omission in Funding/Support Correction In the Original Investigation titled “Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States,” published February 5, 2020, there was an omission in the Funding/Support section in the Article Information. Dr Hu’s research was supported by The Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust. This article has been corrected. REFERENCE 1. Mahase SS, D’Angelo D, Kang J, Hu JC, Barbieri CE, Nagar H. Trends in the use of stereotactic body radiotherapy for treatment of prostate cancer in the United States. JAMA Netw Open. 2020;3(2):e1920471. doi:10.1001/ jamanetworkopen.2019.20471 Open Access. This is an open access article distributed under the terms of the CC-BY License. JAMA Network Open. 2020;3(10):e2027727. doi:10.1001/jamanetworkopen.2020.27727 (Reprinted) October 29, 2020 1/1 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Network Open American Medical Association

Omission in Funding/Support

JAMA Network Open , Volume 3 (10) – Oct 29, 2020

Loading next page...
 
/lp/american-medical-association/omission-in-funding-support-V1UMzB1sGP
Publisher
American Medical Association
Copyright
Copyright 2020. JAMA Network Open.
eISSN
2574-3805
DOI
10.1001/jamanetworkopen.2020.27727
Publisher site
See Article on Publisher Site

Abstract

Correction In the Original Investigation titled “Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States,” published February 5, 2020, there was an omission in the Funding/Support section in the Article Information. Dr Hu’s research was supported by The Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust. This article has been corrected. REFERENCE 1. Mahase SS, D’Angelo D, Kang J, Hu JC, Barbieri CE, Nagar H. Trends in the use of stereotactic body radiotherapy for treatment of prostate cancer in the United States. JAMA Netw Open. 2020;3(2):e1920471. doi:10.1001/ jamanetworkopen.2019.20471 Open Access. This is an open access article distributed under the terms of the CC-BY License. JAMA Network Open. 2020;3(10):e2027727. doi:10.1001/jamanetworkopen.2020.27727 (Reprinted) October 29, 2020 1/1

Journal

JAMA Network OpenAmerican Medical Association

Published: Oct 29, 2020

References